Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medisch Laboratorium Noord (MLN) was a prominent Dutch contract research organization and central laboratory specializing in clinical trial services for the pharmaceutical and biotechnology industries. Established in 1986 and headquartered in Emmen, the company provided comprehensive bioanalytical, clinical chemistry, and hematology services to support Phase I through Phase IV clinical trials. MLN was recognized for its expertise in global specimen logistics, data management, and high-quality analytical testing. In 2006, the company was acquired by the global CRO QPS (Quality Pharmaceutical Services), which integrated MLN's facilities into its European bioanalytical and clinical operations. The site in Emmen continues to serve as a key hub for QPS's bioanalytical and central laboratory services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medisch Laboratorium Noord.